CN105012771A - Application of Chinese herbal preparation to treatment of chronic renal failure - Google Patents
Application of Chinese herbal preparation to treatment of chronic renal failure Download PDFInfo
- Publication number
- CN105012771A CN105012771A CN201510529128.1A CN201510529128A CN105012771A CN 105012771 A CN105012771 A CN 105012771A CN 201510529128 A CN201510529128 A CN 201510529128A CN 105012771 A CN105012771 A CN 105012771A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- renal failure
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses application of a Chinese herbal preparation to treatment of chronic renal failure. The Chinese herbal preparation comprises the following raw materials containing effective constituents by weight: 60 to 90 parts of herba elsholtziae ciliatae, 57 to 87 parts of radix paeoniae alba, 55 to 85 parts of radix morindae officinalis, 53 to 83 parts of saccharum arundinaceum, 50 to 80 parts of limonium sinense, 45 to 75 parts of salvia miltiorrhiza, 42 to 72 parts of herb of thymeleaf speed welt, 40 to 70 parts of rosa multiflora Thunb., 38 to 68 parts of lysimachia paridiformais Franch., 35 to 65 parts of herb of Japanese conehead, 33 to 63 parts of carthamus tinctorius, 31 to 61 parts of root and rhizome of bloodred iris, 30 to 60 parts of polygonum runcinatum, 26 to 56 parts of fiveleaf akebia fruit, 25 to 55 parts of rhizome of elderleaf rodgersflower, and 20 to 50 parts of aleuritopteris argentea. The Chinese herbal preparation has no toxic or side effect, is obvious in renal failure treating effect, low in cost, fast in effect taking and lasting in curative effect, and has no adverse reaction.
Description
Technical field
The present invention relates to the field of Chinese medicines, specifically a kind of Chinese medicine preparation is in the application for the treatment of chronic renal failure.
Background technology
Chronic glomerulonephritis can betide any age, but based on blue or green, the middle age.Most insidious onset, is slowly its basic clinical with hematuria, albuminuria, hypertension, edema.Generally speaking, all have urine examination abnormal (hematuria, albuminuria, cylinderuria), edema and hypertension history, and the course of disease is delayed, and pathology of the renal biopsies inspection can be made a definite diagnosis and is conducive to guiding treatment and judging prognosis.Renal failure should give corresponding determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs for its histological type in early days.
Existing doctor trained in Western medicine for renal failure treatment mainly Immunosuppression transmitting inflammation, antiproliferative effect, alleviate Nephrosclerosis.And should to prevent from or to delay renal function Progressive symmetric erythrokeratodermia worsening, improving or alleviate clinical symptoms and prevent and treat complication for main purpose.But the cure rate of existing western medical treatment generally for renal failure is very low.Effect is undesirable.
After prescription of the present invention is open as the Chinese medicine preparation for the treatment of menoxenia in the application of CN201410427175.0, we find that in a large amount of clinical practice the party is except curing mainly function, also have the good efficacy for the treatment of chronic renal failure.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine preparation in the application for the treatment of chronic renal failure, to solve the problem proposed in above-mentioned background technology.
For achieving the above object, the invention provides following technical scheme:
Chinese medicine preparation is in an application for treatment chronic renal failure, and the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 60 ~ 90 portions of Radix Paeoniae Albas 57 ~ 87 parts of Radix Morindae Officinaliss 55 ~ 85 parts of Radix sacchari arundinacei 53 ~ 83 parts
Herba Limonii Gmelinii 50 ~ 80 parts of Radix Salviae Miltiorrhizaes 45 ~ 75 parts of Herba Veronicae Serpyllifoliaes 42 ~ 72 parts of Fructus rosae multiflorae 40 ~ 70 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 38 ~ 68 parts of Herba Strobilanthis Japonici 35 ~ 65 parts of Flos Carthamis 33 ~ 63 parts of Radix et Rhizoma Iridis Sanguineae 31 ~ 61 parts
Herba Polygoni Runcinati 30 ~ 60 parts of Fructus Akebiaes 26 ~ 56 portions of Rhizoma Rodgersiae 25 ~ 55 parts of Aleuritopteris argentea (Gmel.) Fee 20 ~ 50 parts.
As the further scheme of the present invention: the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 82 portions of Radix Paeoniae Albas 79 parts of Radix Morindae Officinaliss 77 parts of Radix sacchari arundinacei 75 parts
Herba Limonii Gmelinii 72 parts of Radix Salviae Miltiorrhizaes 67 parts of Herba Veronicae Serpyllifoliaes 65 parts of Fructus rosae multiflorae 62 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 61 parts of Herba Strobilanthis Japonici 57 parts of Flos Carthamis 55 parts of Radix et Rhizoma Iridis Sanguineae 53 parts
Herba Polygoni Runcinati 52 parts of Fructus Akebiaes 48 portions of Rhizoma Rodgersiae 47 parts of Aleuritopteris argentea (Gmel.) Fee 42 parts.
The property of medicine of the present invention's Chinese medicine used is as follows:
Herba Elsholtziae Ciliatae: acrid in the mouth, micro-hardship, warm in nature.Dispel the wind and deliver, blood-arresting catamenia-regulating, subduing swelling and detoxicating.For headache due to common cold, paralysis, over-strained hemoptysis, menoxenia, dysmenorrhea, sore and toxic." Guizhou folk medicine " carries: " wind dispelling diaphoresis.Zhitan paralysis, consumptive disease wound is spitted blood, flu, and the moon, man was sick, sore.”
The Radix Paeoniae Alba: bitter in the mouth, acid, cold nature; Return liver, spleen channel.Suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating.Dizzy for having a headache, hypochondriac pain is suffered from abdominal pain, limb pain twin, blood deficiency and yellow complexion, menoxenia, spontaneous sweating." Japan hanako materia medica " carries: " control wind and mend consumptive disease, all diseases of main woman, and antenatal rear all diseases, Tong Yueshui, relieving restlessness of bringing down a fever, QI invigorating, controls the capable hot disease in sky, pestilence miasma mania and irritation, and married woman's blood is transported, and hemorrhoidal hamorrhage rushes down blood, hemorrhoid complicated by anal fistula carbuncle on the back, skin ulcer scabies, headache, improving eyesight, conjunctival congestion, bulbar conjunctiva polyp.”
Radix Morindae Officinalis: sweet in the mouth, pungent, slightly warm in nature; Return kidney, Liver Channel.Kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.For impotence and seminal emission, cold womb is infertile, menoxenia, and few abdomen cold type of pain, rheumatic arthralgia, muscles and bones flaccidity is soft." detailed outline " carries: " control beriberi, go wind disease, sea of enriching blood.”
Radix sacchari arundinacei: sweet in the mouth, light, cool in nature.Promoting blood circulation to restore menstrual flow, sensible diuretic.For traumatic injury, muscles and bones wind pain, amenorrhea, menoxenia, edema distention of the abdomen caused by various parasites.Amplification on Canon of Materia Medica carries: " the deficient people of prolonged illness eats it, QI invigorating.”
Herba Limonii Gmelinii: bitter in the mouth, salty, warm in nature.Promoting blood circulation and hemostasis, warming middle-JIAO and strengthening the spleen, strengthening by means of tonics.For menoxenia, dysfunctional uterine hemorrhage, bleeding hemorrhoids, gastric ulcer, insufficiency of the spleen edema." Chinese Herbal Medicine in Xinjiang handbook " carries: " hemostasis dissipating blood stasis.Control dysfunctional uterine hemorrhage, cervical cancer and other are hemorrhage.”
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, Liver Channel.Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea dysmenorrhea, breast ventral spine pain, pyretic arthralgia pain, dysphoria and insomnia, hepatosplenomegaly." Japan hanako materia medica " carries: " sedate of reposing, tonneau GUAN-pulse.Control cold and hot labor, arthralgia, extremity are unsuccessful; Evacuation of pus pain relieving, granulation promoting is put on flesh; Broken stagnated blood, mends new hemopoietic; Peaceful tire, fall stillborn fetus; Under hemostasis metrorrhagia and leukorrhagia, adjust married woman's passages through which vital energy circulates irregular, blood evil thought is tired of; Malignant boil scabies, wart is gone to live in the household of one's in-laws on getting married toxic swelling, erysipelas; Headache, acute conjunctivitis, hot temperature is mad vexed.”
Herba Veronicae Serpyllifoliae: sweet in the mouth, hardship, puckery, property is put down; Return Liver Channel.Promoting blood circulation to remove blood stasis, hemostasis removing toxic substances.For traumatic injury, menoxenia, wound hemorrhage, burn and scald." Shaanxi Chinese herbal medicine " carries: " promoting blood circulation to remove blood stasis, hemostasis, removing toxic substances.Control traumatic injury, inside have blood stasis, traumatic hemorrhage, menoxenia, venom.”
Fructus rosae multiflorae: sour in the mouth, cold nature; Return lung, spleen, liver, urinary bladder channel.Heat-clearing and toxic substances removing, expelling wind and activating blood circulation, inducing diuresis to remove edema.For sore and toxic, rheumatic arthralgia, articular instability, menoxenia, edema, dysuria." modern Practical Chinese medicinal " carries: " except rheumatism.The dermatosiss such as edema, menoxenia, dysuria, beriberi generalized edema with distention of the chest and abdomen, syphilitic skin lesions incrustation, tinea skin ulcer are caused to generalized edema with distention of the chest and abdomen is breathed with cough, person is effective with this for constipation and anuresis, trusted subordinate's feeling of distension and oppression.”
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae): acrid in the mouth, hardship, warm in nature, poisonous.Expelling wind and removing dampness, promoting blood circulation to remove blood stasis.For cough due to wind and cold, rheumatic numbness, pain, menoxenia, traumatic consumptive injury." conventional Chinese herbal medicine handbook " carries: " promoting blood circulation and stopping pain.Control traumatic injury, cough due to wind and cold, rheumatalgia, consumptive disease are hindered.”
Hongze is blue: bitter in the mouth, micro-pungent, warm in nature; Return liver, spleen channel.Promoting blood circulation to restore menstrual flow, blood stasis dispelling row water.For menoxenia, dysmenorrhea amenorrhea, puerperal abdonimal pain, lump in the abdomen, body and face edema." Chinese herbal medicine is commonly used in Sichuan " carries: " the capable water of repercussive, soothing liver-QI falls apart strongly fragrant.Control menoxenia, puerperal dripping stomachache, bruise, lump in the abdomen carbuncle, traumatic injury and body and face edema.”
Flos Carthami: acrid in the mouth, warm in nature; Return liver, kidney channel.Promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.For amenorrhea, lump in the abdomen is had difficult labour, and stillborn fetus, disease that postpartum lochia can't go, blood stasis are had a pain, carbuncle, injury from falling down." detailed outline " carries: " invigorate blood circulation, moisturize, pain relieving, loose swollen, stimulate the menstrual flow.”
Radix et Rhizoma Iridis Sanguineae: acrid in the mouth, sweet, warm in nature.Promoting blood flow to regulate menstruation, eliminating stasis to stop pain, spleen invigorating removing food stagnancy.For menoxenia, dysmenorrhea amenorrhea, treating swelling and pain by traumatic injury, rheumatic ostalgia, infantile malnutrition, neurasthenia.
Herba Polygoni Runcinati: mildly bitter flavor, puckery, property is put down.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, removing toxic substances and promoting subsidence of swelling.For acute gastroenteritis, spitting of blood of spitting blood, bleeding hemorrhoids, menoxenia, traumatic injury, mastitis are controlled in external." Chinese herbal medicine is commonly used in Sichuan " carries: " heat clearing away is invigorated blood circulation.Control internal injury, heat in blood giddy headache, redly to collapse, amenorrhea, hypopyretic cough, dysentery with red and white feces, carbuncle poison malignant boil.”
Fructus Akebiae: sweet in the mouth, cold in nature; Return liver, stomach, urinary bladder channel.Dispersing the stagnated liver-QI for regulating the stomach, promoting blood circulation and stopping pain, hard masses softening and resolving.For stagnation of liver-QI and stomach-QI, the side of body helps distending pain, and diet does not disappear, amenorrhea dysmenorrhea, goiter scrofula, malignant tumor." pharmacognosy " carries: " promoting the circulation of QI, invigorates blood circulation, parasite killing, removing toxic substances, pain relieving.For stomachache due to hyperactive liver-QI attacking the stomach, hypochondriac pain, the diseases such as menstrual pain.”
Rhizoma Rodgersiae: bitter in the mouth, puckery, cool in nature; Return stomach, spleen, lung meridian.Clearing away heat and cooling blood, menstruction regulating and pain relieving.For enteritis and dysentery, dysmenorrhea, menorrhagia, rheumatic arthritis, traumatic injury, traumatic hemorrhage is controlled in external." Guizhou medical herbs " carries: " circulation of qi promoting, promoting blood flow to regulate menstruation.Control epersalgia cough, pain, traumatic injury pain, menoxenia.”
Aleuritopteris argentea (Gmel.) Fee: acrid in the mouth, sweet, property is put down; Return lung, Liver Channel.Expelling phlegm for arresting cough, promoting blood circulation to restore menstrual flow.For cough, menoxenia, amenorrhea is suffered from abdominal pain, leucorrhea with red and white discharge, pulmonary tuberculosis hemoptysis." Henan Chinese herbal medicine handbook " carries: " promoting blood flow to regulate menstruation, damp eliminating, cold expelling, pain relieving.”
Compared with prior art, the invention has the beneficial effects as follows:
No side effects of the present invention, can to improve significantly effect to renal failure.Cost is low, rapid-action simultaneously, curative effect lasting, and has no adverse reaction.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, a kind of Chinese medicine preparation is in the application for the treatment of chronic renal failure, and the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 60 portions of Radix Paeoniae Albas 57 parts of Radix Morindae Officinaliss 55 parts of Radix sacchari arundinacei 53 parts
Herba Limonii Gmelinii 50 parts of Radix Salviae Miltiorrhizaes 45 parts of Herba Veronicae Serpyllifoliaes 42 parts of Fructus rosae multiflorae 40 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 38 parts of Herba Strobilanthis Japonici 35 parts of Flos Carthamis 33 parts of Radix et Rhizoma Iridis Sanguineae 31 parts
Herba Polygoni Runcinati 30 parts of Fructus Akebiaes 26 portions of Rhizoma Rodgersiae 25 parts of Aleuritopteris argentea (Gmel.) Fee 20 parts.
Embodiment 2
In the embodiment of the present invention, a kind of Chinese medicine preparation is in the application for the treatment of chronic renal failure, and the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 90 portions of Radix Paeoniae Albas 87 parts of Radix Morindae Officinaliss 85 parts of Radix sacchari arundinacei 83 parts
Herba Limonii Gmelinii 80 parts of Radix Salviae Miltiorrhizaes 75 parts of Herba Veronicae Serpyllifoliaes 72 parts of Fructus rosae multiflorae 70 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 68 parts of Herba Strobilanthis Japonici 65 parts of Flos Carthamis 63 parts of Radix et Rhizoma Iridis Sanguineae 61 parts
Herba Polygoni Runcinati 60 parts of Fructus Akebiaes 56 portions of Rhizoma Rodgersiae 55 parts of Aleuritopteris argentea (Gmel.) Fee 50 parts.
Embodiment 3
In the embodiment of the present invention, a kind of Chinese medicine preparation is in the application for the treatment of chronic renal failure, and the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 82 portions of Radix Paeoniae Albas 79 parts of Radix Morindae Officinaliss 77 parts of Radix sacchari arundinacei 75 parts
Herba Limonii Gmelinii 72 parts of Radix Salviae Miltiorrhizaes 67 parts of Herba Veronicae Serpyllifoliaes 65 parts of Fructus rosae multiflorae 62 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 61 parts of Herba Strobilanthis Japonici 57 parts of Flos Carthamis 55 parts of Radix et Rhizoma Iridis Sanguineae 53 parts
Herba Polygoni Runcinati 52 parts of Fructus Akebiaes 48 portions of Rhizoma Rodgersiae 47 parts of Aleuritopteris argentea (Gmel.) Fee 42 parts.
In order to understand the therapeutic effect of Chinese medicine preparation of the present invention, in 60 rats, do zoopery with the present invention, experimental technique is as follows:
1, laboratory animal: Male Wistar Rats 60, body weight 250 ± 20 grams, is provided by Jilin University's Experimental Animal Center.
Experimental agents: embodiment 4 obtains a kind of Chinese medicine preparation for the treatment of chronic renal failure, with hot water dissolving, makes every mL respectively containing a kind of Chinese medicine preparation 1.2g, 2.4g and 4.8g treating chronic renal failure of the present invention, respectively basic, normal, high group to drug solns.Adenine feedstuff: add adenine in normal diet, fully mixes, and makes solid feed, and NIAODUQING KELI is provided by Kangchen Pharmaceutical Co., Ltd., Guangzhou.
Experiment reagent: hematuria creatinine, blood urea nitrogen and urine protein quantitation test kit.
Grouping and modeling: 60 rats are divided into normal group 10 at random, modeling group 50.Modeling group rat gives above-mentioned adenine feedstuff, and by body weight to adenine 300mg/kg, normal group is to normal diet.Modeling 15 days, terminate a few days ago in experiment, rat is placed in metabolic cage, and water is can't help in fasting, collects urine, measures urine volume, urine creatine, blood urea nitrogen, urine protein.
3, treat
Be model group, the basic, normal, high dosage group of Chinese medicine preparation of the present invention and positive controls by modeling component, the dosage of basic, normal, high dosage group, give basic, normal, high group of Chinese medicine preparation of the present invention to drug solns 0.5ml/100g body weight gavage respectively, once a day, positive controls NIAODUQING KELI 0.27g/100g body weight rat oral gavage, once a day.Successive administration 6 weeks, terminate a few days ago in experiment, rat is placed in metabolic cage, and water is can't help in fasting, collects urine, detects index of correlation.Within after last administration one hour, put to death rat, get blood and carry out biochemical indicator detection, get kidney simultaneously, carry out pathology section examination.
4, observation index
Detect: urine creatine (Cr), blood urea nitrogen (BUN), 24h urine protein quantitation
5, renal tissue change
1) kidney outward appearance
Normal group: kidney is brown, quality is solid glossy.
Model group: kidney obvious tumefaction, quality is soft, and in canescence, lack gloss, peplos etc. easily peel off.NIAODUQING KELI group and Chinese medicine preparation group: kidney enlargement, volume increases, and become taupe, quality is more solid, slightly gloss.
2) pathological section Microscopic observation
Normal group: nephridial tissue structure is without exception.Glomerule shows congested, and renal cells is normal, has no yellowish-brown crystallization deposition in renal tubules, renal tubular interstitium without congested, ooze out.
Model group: Pathological change relates to glomerule, renal tubules and renal interstitial, mainly renal tubules and renal interstitial.Intralesional part renal tubules destroys, and atresia, has cell infiltration and proliferation of fibrous tissue in interstitial, have lymph follicle shape structure.In Tubulointerstitum, visible many yellowish-brown adenine metabolite crystallization depositions, have foreign body granuloma to be formed, part tubular ectasia around crystallization, wherein visible albumen and granular cast.
Chinese medicine preparation group: nephridial tissue pathological changes is consistent with model group.But pathological changes comparatively model group alleviates, cell infiltration and proliferation of fibrous tissue area little compared with model group; Renal tubules and the intraparenchymatous crystalline solid of kidney of expansion are also less.Middle dosage Chinese medicine preparation administration group nephridial tissue pathological changes is smaller.Part nephridial tissue and Normal group are more similar.
Positive controls: nephridial tissue pathological changes is consistent with model group.But pathological changes comparatively model group has and alleviates, nephron atrophy, disappearance, cell infiltration and the less and majority of proliferation of fibrous tissue area are confined to the cortical section of nearly tunicle; Part nephridial tissue and Normal group are more similar.
Result shows: can reduce rat serum BUN, Cr, reduces urine protein.
Beneficial effect: Chinese medicine preparation of the present invention has mitigation to the symptom of CRF rat caused by adenine, and has the effect of reduction serum creatinine (Cr), blood urea nitrogen (BUN) and twenty-four-hour urine albumen.In Chinese medicine preparation of the present invention, dosed administration group and model group contrast, and blood urea nitrogen and urine protein all have pole significant difference.The numerical value of urine creatine and blood urea nitrogen is all less than positive controls, refers to table 1.
Table 1 Chinese medicine preparation of the present invention to CRP rat BUN, Cr caused by adenine, the impact (X ± S) of urine protein level
| Group | Number of animals | Dosage (g/kg) | BUN（mmol/L） | Cr(μmol/L) | Urine protein (g/24h) |
| Normal group | 10 | - | 6.19±0.05 | 56.21±3.65 | 8.57±1.38 |
| Model group | 10 | - | 27.29±1.89 *** | 88.42±5.71 ** | 20.21±1.30 *** |
| Chinese medicine preparation group (height) | 10 | 2.4 | 12.70±1.65 ***? | 58.81±1.32 | 10.09±1.71 * |
| Chinese medicine preparation group (in) | 10 | 1.2 | 8.13±1.12 *** | 61.56±1.29 ** | 11.88±0.92 *** |
| Chinese medicine preparation group (low) | 10 | 0.6 | 15.06±1.50 *** | 88.72±1.11 ** | 15.49±1.59 *** |
| Positive controls | 10 | 2.7 | 15.95±2.01 *** | 62.25±2.00 ** | 9.90±1.41 * |
Note: compare with normal group
*p < 0.05,
*p < 0.01,
* *p < 0.001; Compare with model group
△p < 0.05,
△ △p < 0.01,
△ △ △p < 0.001.
The present invention is used for the treatment of 100 routine patients with chronic renal failure, takes after 2 months and cure 65 examples, effective 25 examples, effective 5 examples, invalid 5 examples, total effective rate is 95%.
Be described below by way of the drug effect of several model case to the Chinese medicine of the embodiment of the present invention:
Case 1
Chen, man, 61 years old.Symptom: renal failure (renal insufficiency).Prescription: embodiment 1.After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better, and recovers after 1 year.
Case 2
Lee so-and-so, man, 61 years old.Symptom: renal failure initial stage.Prescription: embodiment 2.After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better, and recovers after half a year.
Case 3
Week so-and-so, man, 65 years old.Symptom: renal failure initial stage.Prescription: embodiment 3.After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better.
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.
Claims (2)
1. Chinese medicine preparation is in an application for treatment chronic renal failure, it is characterized in that, the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 60 ~ 90 portions of Radix Paeoniae Albas 57 ~ 87 parts of Radix Morindae Officinaliss 55 ~ 85 parts of Radix sacchari arundinacei 53 ~ 83 parts
Herba Limonii Gmelinii 50 ~ 80 parts of Radix Salviae Miltiorrhizaes 45 ~ 75 parts of Herba Veronicae Serpyllifoliaes 42 ~ 72 parts of Fructus rosae multiflorae 40 ~ 70 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 38 ~ 68 parts of Herba Strobilanthis Japonici 35 ~ 65 parts of Flos Carthamis 33 ~ 63 parts of Radix et Rhizoma Iridis Sanguineae 31 ~ 61 parts
Herba Polygoni Runcinati 30 ~ 60 parts of Fructus Akebiaes 26 ~ 56 portions of Rhizoma Rodgersiae 25 ~ 55 parts of Aleuritopteris argentea (Gmel.) Fee 20 ~ 50 parts.
2. Chinese medicine preparation according to claim 1 is in the application for the treatment of chronic renal failure, it is characterized in that, the raw material composition of described Chinese medicine preparation effective ingredient and parts by weight are:
Herba Elsholtziae Ciliatae 82 portions of Radix Paeoniae Albas 79 parts of Radix Morindae Officinaliss 77 parts of Radix sacchari arundinacei 75 parts
Herba Limonii Gmelinii 72 parts of Radix Salviae Miltiorrhizaes 67 parts of Herba Veronicae Serpyllifoliaes 65 parts of Fructus rosae multiflorae 62 parts
Herba Chloranthi Henryi (Herba Choranthi seu Lysimachiae) 61 parts of Herba Strobilanthis Japonici 57 parts of Flos Carthamis 55 parts of Radix et Rhizoma Iridis Sanguineae 53 parts
Herba Polygoni Runcinati 52 parts of Fructus Akebiaes 48 portions of Rhizoma Rodgersiae 47 parts of Aleuritopteris argentea (Gmel.) Fee 42 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510529128.1A CN105012771A (en) | 2015-08-26 | 2015-08-26 | Application of Chinese herbal preparation to treatment of chronic renal failure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510529128.1A CN105012771A (en) | 2015-08-26 | 2015-08-26 | Application of Chinese herbal preparation to treatment of chronic renal failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105012771A true CN105012771A (en) | 2015-11-04 |
Family
ID=54403310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510529128.1A Pending CN105012771A (en) | 2015-08-26 | 2015-08-26 | Application of Chinese herbal preparation to treatment of chronic renal failure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105012771A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998963A (en) * | 2016-07-25 | 2016-10-12 | 李永伟 | Traditional Chinese medicine composition for treating chronic renal failure and application of traditional Chinese medicine composition for treating chronic renal failure |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109772A (en) * | 1993-03-06 | 1995-10-11 | 管益君 | Medicine and preparing process thereof |
| CN102475753A (en) * | 2010-11-30 | 2012-05-30 | 西安世纪盛康药业有限公司 | Kidney-health patch for treating chronic renal failure and preparation method thereof |
-
2015
- 2015-08-26 CN CN201510529128.1A patent/CN105012771A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109772A (en) * | 1993-03-06 | 1995-10-11 | 管益君 | Medicine and preparing process thereof |
| CN102475753A (en) * | 2010-11-30 | 2012-05-30 | 西安世纪盛康药业有限公司 | Kidney-health patch for treating chronic renal failure and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 李顺民等主编: "《实用肾病临床手册》", 30 November 2014 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998963A (en) * | 2016-07-25 | 2016-10-12 | 李永伟 | Traditional Chinese medicine composition for treating chronic renal failure and application of traditional Chinese medicine composition for treating chronic renal failure |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN102018836B (en) | Chinese traditional medicine for treating mixed hemorrhoids | |
| CN102274464B (en) | Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis | |
| CN102133379B (en) | Traditional Chinese medicine pill for treating gynecopathy | |
| CN104189278B (en) | Traditional Chinese medicine preparation for treating menstrual disorder and preparation method thereof | |
| CN101618201B (en) | Medicine for curing vulvar leukoplakia | |
| CN102743543B (en) | Oral traditional Chinese drug preparation for treating abnormal leucorrhea | |
| CN104689231A (en) | Traditional Chinese medicine composition for treating chronic renal failure and application thereof | |
| CN105012771A (en) | Application of Chinese herbal preparation to treatment of chronic renal failure | |
| CN104491670A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
| CN104288581A (en) | Traditional Chinese medicine for treating threatened abortion | |
| CN105106846B (en) | Treat the formula of Chinese materia medica preparation of uterus adenomyosis | |
| CN104324185A (en) | Traditional Chinese medicine composition for treating leukorrhagia and preparation method thereof | |
| CN105031370A (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN103494991B (en) | Traditional Chinese medicine preparation for treating female metrorrhagia and preparation method thereof | |
| CN104189615B (en) | Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis, and preparation method of traditional Chinese medicine preparation | |
| CN104721746A (en) | Traditional Chinese medicine composition for treating chronic renal failure and application of traditional Chinese medicine composition | |
| CN106310137A (en) | Traditional Chinese medicine composition for treating qi stagnation and blood stasis syndrome due to coronary disease and angina and preparation method thereof | |
| CN105963619A (en) | Traditional Chinese medicine composition for treating uterus coldness infertility | |
| CN106361881A (en) | Decoction medicament for treating scrotal eczema and preparation method of decoction medicament | |
| CN105213975A (en) | A kind of pharmaceutical composition and application thereof for the treatment of liver cirrhosis | |
| CN105288473A (en) | Traditional Chinese medicine composition for treating lupus erythematosus and application thereof | |
| CN105535674A (en) | A medicine for treating chronic cervicitis | |
| CN104623387A (en) | Pharmaceutical composition for treating chronic nephritis | |
| CN104383467A (en) | Traditional Chinese medicine for treating liver-qi depression type cervical cancer and preparation method of traditional Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151104 |